340B Drug Program: Key Trends for 2023 | Baker Donelson
Throughout 2022, the 340B Drug Program (340B) and participating hospital systems experienced myriad new developments. From continued disputes with drug manufacturers to a landmark U.S....
Stay updated with breaking news from B Drug Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Throughout 2022, the 340B Drug Program (340B) and participating hospital systems experienced myriad new developments. From continued disputes with drug manufacturers to a landmark U.S....
As expected, CMS per-day penalties rise drastically in 2021 following agency switch … Supreme Court to hear arguments in case seeking to reverse cuts to 340B Drug Program … Rushed care by nursing home aides tied to behavioral responses from residents with Alzheimer’s
Deputy Secretary and CMS Administrator Picks Would Fill Two Critical Policy Positions On Thursday, the Senate Finance Committee held a confirmation hearing for two of the most important health policy officials nominated by President Biden, Chiquita Brooks-LaSure (Administrator, Centers for Medicare and Medicaid Services) and Andrea Palm (Deputy Secretary). These are two critical policy positions for Congress to help fill, as the Deputy Secretary is often comparable to the Chief Operating Officer of a cabinet agency and the CMS Administrator helms the implementation of public health progra...
Monday, January 11, 2021 DHCS”) will be transitioning all Medi-Cal pharmacy benefits from managed care to fee-for-service (“ FFS”). This new system to administer FFS pharmacy benefits is being called “Medi-Cal Rx” and was developed by DHCS in response California Governor Gavin Newsom’s January 7, 2019 executive order (the “ Order”), which instructed DHCS to transition all Medi-Cal pharmacy benefits to FFS by January 1, 2021. The rationale behind the Order is to combat rising prices for prescription drugs by increasing the State’s bargaining power in negotiati...